Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

Co-Diagnostics, Inc.(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Exclusive: Co-Diagnostics reaches regulatory milestone for PCR respiratory test platform

Co-Diagnostics Inc. CODX on Wednesday said it completed clinical and analytical performance studies for the Co-Dx PCR Flu A/B ...
Yahoo Finance

All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy

Investors might want to bet on Co-Diagnostics, Inc. (CODX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Benzinga.com

Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership

The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...
Nasdaq

Has CoDiagnostics, Inc. (CODX) Outpaced Other Medical Stocks This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is CoDiagnostics, Inc. (CODX) one of those stocks right now? A ...
Nasdaq

Is Co-Diagnostics (CODX) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Co-Diagnostics (CODX) is a stock that can certainly grab the attention of many ...